Western Wheatgrass
NDC 49288-0613

View dosage, usage, ingredients, routes, and UNII mappings.
Table of Contents
  1. Product Information
  2. Product Packages
  3. What is NDC 49288-0613?
  4. Western Wheatgrass Uses
  5. Active Ingredients UNII Codes
  6. Inactive Ingredients UNII Codes
  7. NDC to RxNorm Crosswalk

Product Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Western Wheatgrass is a BLA-approved product labeled by Antigen Laboratories, Inc.. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a product. This product entry covers the primary NDC 49288-0613 and 5 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.

Primary Identification

NDC Product Code:
49288-0613
Proprietary Name:
Western Wheatgrass
Product Type: [3]
INACTIVATED PRODUCT and EXCLUDED the from NDC Directory
Code Navigator:

Labeler & Regulatory Data

Labeler Name: [5]
Antigen Laboratories, Inc.
Labeler Code:
49288
Product Label ID:
c7d383a6-94b8-4101-8a4c-fa7747a21468
FDA Application Number: [6]
BLA102223
Marketing Category: [8]
BLA - A product marketed under an approved Biologic License Application.

Marketing Timeline

Start Marketing Date: [9]
03-23-1974
Listing Expiration Date: [11]
12-31-2017
Exclude Flag: [12]
I

Code Structure Chart

Product Details

What is NDC 49288-0613?

The NDC code 49288-0613 is assigned by the FDA to the product Western Wheatgrass. This pharmaceutical product is labeled by Antigen Laboratories, Inc. and is currently categorized as listed product. In terms of distribution, this product is available in 5 different package configurations. The associated package NDC(s) include: 49288-0613-1, 49288-0613-2, 49288-0613-3, 49288-0613-4, 49288-0613-5. Beyond standard identification, this entry provides technical data including pharmacologic classes, UNII ingredient references, and RxNorm cross-referencing for healthcare systems.

What are the uses of this product?

Allergenic extract is used for diagnostic testing and for the treatment (immunotherapy) of patients whose histories indicate that upon natural exposure to the allergen, they experience allergic symptoms. Confirmation is determined by skin testing. Diagnostic use of allergenic extracts usually begins with direct skin testing. This product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing.

Which are the associated UNII Codes?

The UNII codes for the active ingredients in this product are:

  • BETA VULGARIS POLLEN (UNII: W7NU4B5CIY)
  • BETA VULGARIS POLLEN (UNII: W7NU4B5CIY) (Active Moiety)
  • ZEA MAYS POLLEN (UNII: 74PD8J616H)
  • ZEA MAYS POLLEN (UNII: 74PD8J616H) (Active Moiety)
  • MELILOTUS ALBUS POLLEN (UNII: 9L67M8B78R)
  • MELILOTUS ALBUS POLLEN (UNII: 9L67M8B78R) (Active Moiety)
  • POA COMPRESSA POLLEN (UNII: 50HCQ1NYV5)
  • POA COMPRESSA POLLEN (UNII: 50HCQ1NYV5) (Active Moiety)
  • POA ANNUA POLLEN (UNII: 7U437HHU5C)
  • POA ANNUA POLLEN (UNII: 7U437HHU5C) (Active Moiety)
  • BROMUS SECALINUS POLLEN (UNII: Q4T1SJ3046)
  • BROMUS SECALINUS POLLEN (UNII: Q4T1SJ3046) (Active Moiety)
  • BROMUS INERMIS POLLEN (UNII: 766QT72BK6)
  • BROMUS INERMIS POLLEN (UNII: 766QT72BK6) (Active Moiety)
  • PHALARIS ARUNDINACEA POLLEN (UNII: FAY1Y90VJ9)
  • PHALARIS ARUNDINACEA POLLEN (UNII: FAY1Y90VJ9) (Active Moiety)
  • TYPHA LATIFOLIA POLLEN (UNII: 341PDX5PLM)
  • TYPHA LATIFOLIA POLLEN (UNII: 341PDX5PLM) (Active Moiety)
  • SORGHUM HALEPENSE POLLEN (UNII: 577VA5B4HP)
  • SORGHUM HALEPENSE POLLEN (UNII: 577VA5B4HP) (Active Moiety)
  • ARRHENATHERUM ELATIUS POLLEN (UNII: B55BD1QM4Q)
  • ARRHENATHERUM ELATIUS POLLEN (UNII: B55BD1QM4Q) (Active Moiety)
  • AVENA SATIVA POLLEN (UNII: A7IKY24TR7)
  • AVENA SATIVA POLLEN (UNII: A7IKY24TR7) (Active Moiety)
  • ELYMUS REPENS POLLEN (UNII: ON2T85TA2O)
  • ELYMUS REPENS POLLEN (UNII: ON2T85TA2O) (Active Moiety)
  • SECALE CEREALE POLLEN (UNII: I6KAZ8AO1O)
  • SECALE CEREALE POLLEN (UNII: I6KAZ8AO1O) (Active Moiety)
  • SORGHUM BICOLOR SSP. DRUMMONDII POLLEN (UNII: B43R30VP73)
  • SORGHUM BICOLOR SSP. DRUMMONDII POLLEN (UNII: B43R30VP73) (Active Moiety)
  • DISTICHLIS SPICATA POLLEN (UNII: GOA51670YV)
  • DISTICHLIS SPICATA POLLEN (UNII: GOA51670YV) (Active Moiety)
  • HOLCUS LANATUS POLLEN (UNII: 70O1TP6H01)
  • HOLCUS LANATUS POLLEN (UNII: 70O1TP6H01) (Active Moiety)
  • TRITICUM AESTIVUM POLLEN (UNII: F1KAH8374D)
  • TRITICUM AESTIVUM POLLEN (UNII: F1KAH8374D) (Active Moiety)
  • PASCOPYRUM SMITHII POLLEN (UNII: 6AU0ZD8T1O)
  • PASCOPYRUM SMITHII POLLEN (UNII: 6AU0ZD8T1O) (Active Moiety)

Which are the Inactive Ingredients associated UNII Codes?

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

What is the NDC to RxNorm Crosswalk for this product?

RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:
  • RxCUI: 1006509 - tall oat grass pollen extract 50 MG/ML Injectable Solution
  • RxCUI: 1006509 - Arrhenatherum elatius pollen extract 0.05 GM/ML Injectable Solution
  • RxCUI: 1006509 - Arrhenatherum elatius pollen extract 1 GM per 20 ML Injectable Solution
  • RxCUI: 1006509 - Arrhenatherum elatius pollen extract 50 MG/ML Injectable Solution
  • RxCUI: 1014734 - Canadian bluegrass pollen extract 50 MG/mL Injectable Solution

* Please review the full disclaimer at the bottom of this page.

Product & Regulatory Definitions
What is the Labeler Name? Name of Company corresponding to the labeler code segment of the Product NDC.
What is the FDA Application Number? This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
What is the Marketing Category? Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
What is the Start Marketing Date? This is the date that the labeler indicates was the start of its marketing of the drug product.
What is the Listing Expiration Date? This is the date when the listing record will expire if not updated or certified by the product labeler.
What is the NDC Exclude Flag? This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions, or because the listing certification is expired, or because the listing data was inactivated by FDA, or because it was discontinued by the labeler. Possible values in this field are: "D", "E", "I", "N", "U".